| Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis H Du, X Li, N Su, L Li, X Hao, H Gao, JSW Kwong, PO Vandvik, X Yang, ... Heart 105 (15), 1149-1159, 2019 | 45 | 2019 |
| Anticoagulant chitosan-kappa-carrageenan composite hydrogel sorbent for simultaneous endotoxin and bacteria cleansing in septic blood Y Li, J Li, Z Shi, Y Wang, X Song, L Wang, M Han, H Du, C He, W Zhao, ... Carbohydrate polymers 243, 116470, 2020 | 44 | 2020 |
| Exenatide in obese or overweight patients without diabetes: a systematic review and meta-analyses of randomized controlled trials N Su, Y Li, T Xu, L Li, JSW Kwong, H Du, K Ren, Q Li, J Li, X Sun, S Li, ... International Journal of Cardiology 219, 293-300, 2016 | 24 | 2016 |
| A narrative review of exosomes in vascular calcification Z Qin, R Liao, Y Xiong, L Jiang, J Li, L Wang, M Han, S Sun, J Geng, ... Annals of Translational Medicine 9 (7), 2021 | 20 | 2021 |
| Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis J Li, H Du, Y Wang, B Aertgeerts, G Guyatt, Q Hao, Y Shen, L Li, N Su, ... Heart 108 (16), 1296-1302, 2022 | 19 | 2022 |
| Global burden attributable to high low-density lipoprotein-cholesterol from 1990 to 2019 H Du, Q Shi, P Song, XF Pan, X Yang, L Chen, Y He, G Zong, Y Zhu, B Su, ... Frontiers in cardiovascular medicine 9, 903126, 2022 | 19 | 2022 |
| Effect of anticoagulant administration on the mortality of hospitalized patients with COVID-19: an updated systematic review and meta-analysis L Jiang, Y Li, H Du, Z Qin, B Su Frontiers in medicine 8, 698935, 2021 | 19 | 2021 |
| Trends of the global burden of disease attributable to cannabis use disorder in 204 countries and territories, 1990–2019: Results from the Disease Burden Study 2019 H Shao, H Du, Q Gan, D Ye, Z Chen, Y Zhu, S Zhu, L Qu, J Lu, Y Li, ... International Journal of Mental Health and Addiction, 1-23, 2023 | 18 | 2023 |
| Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies Y Wang, S Zhan, H Du, J Li, SU Khan, B Aertgeerts, G Guyatt, Q Hao, ... BMJ medicine 1 (1), 2022 | 17 | 2022 |
| Predictors of successful discontinuation from renal replacement therapy during AKI: A meta‐analysis L Wang, J Li, S Sun, H Du, P Chen, Y Xu, Y Shen, S Xin, Y Dan, H Li, ... Seminars in dialysis 34 (2), 137-146, 2021 | 7 | 2021 |
| New evidence-based clinical practice guideline timely supports hospital infection control of coronavirus disease 2019 S Li, Z Zong, X Sun, W Li Precision Clinical Medicine 3 (1), 1-2, 2020 | 7 | 2020 |
| Associations between 25-hydroxyvitamin D, kidney function, and insulin resistance among adults in the United States of America J Geng, Y Qiu, Y Li, J Li, R Liao, H Du, L Jiang, L Wang, Z Qin, Q Yang, ... Frontiers in nutrition 8, 716878, 2022 | 6 | 2022 |
| Glycated haemoglobin A1c variability score elicits kidney function decline in Chinese people living with type 2 diabetes Y Zhou, H Huang, X Yan, S Hapca, S Bell, F Qu, L Liu, X Chen, S Zhang, ... Journal of Clinical Medicine 11 (22), 6692, 2022 | 4 | 2022 |
| Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults Y Xiang, L Gan, H Du, Q Hao, B Aertgeerts, S Li, M Hu International Journal of Technology Assessment in Health Care 39 (1), e53, 2023 | 2 | 2023 |
| Values and preferences of medication use in patients for primary and secondary prevention of cardiovascular diseases: a mixed-methods exploratory study LI Shenghan, DU Heyue, AN Kang, HE Longtao, LI Jing, LI Sheyu Chinese General Practice Journal, 2024 | | 2024 |
| Trends of Global Disease Burden Attributable to Diet low in Polyunsaturated fatty Acidsl From 1990 to 2019: A Global Burden of Disease Study Analysis A Abu-Haniyeh, H Du Journal of Clinical Lipidology 18 (4), e520-e521, 2024 | | 2024 |
| Minority Representation in studies cited as references in National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer. Z Zheng, L Qu, H Du, CY Wang, X Cao, Y Xiong, B Yim, S Gupta Journal of Clinical Oncology 40 (16_suppl), e18511-e18511, 2022 | | 2022 |
